These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15851523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. B cells in rheumatoid arthritis: from hypothesis to the clinic.
    Keystone EC.
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii8-ii12. PubMed ID: 15851525
    [Abstract] [Full Text] [Related]

  • 4. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N, Mimori T.
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [Abstract] [Full Text] [Related]

  • 5. Long term treatment of rheumatoid arthritis with rituximab.
    Caporali R, Caprioli M, Bobbio-Pallavicini F, Bugatti S, Montecucco C.
    Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
    [Abstract] [Full Text] [Related]

  • 6. What is the role of rituximab in the treatment of rheumatoid arthritis?
    Atzeni F, Doria A, Turiel M, Sarzi-Puttini P.
    Autoimmun Rev; 2007 Sep; 6(8):553-8. PubMed ID: 17854748
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
    Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, van Laar JM.
    Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
    [Abstract] [Full Text] [Related]

  • 8. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F, Isenberg DA.
    Handb Exp Pharmacol; 2008 Dec; (181):163-81. PubMed ID: 18071946
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells.
    De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G.
    Arthritis Rheum; 2002 Aug; 46(8):2029-33. PubMed ID: 12209504
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis.
    Korhonen R, Moilanen E.
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):13-21. PubMed ID: 19686542
    [Abstract] [Full Text] [Related]

  • 11. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
    Roll P, Dörner T, Tony HP.
    Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
    [Abstract] [Full Text] [Related]

  • 12. Current aspects of anti-CD20 therapy in rheumatoid arthritis.
    Jacobi AM, Dörner T.
    Curr Opin Pharmacol; 2010 Jun; 10(3):316-21. PubMed ID: 20189875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy.
    Bokarewa M, Lindholm C, Zendjanchi K, Nadali M, Tarkowski A.
    Scand J Immunol; 2007 Oct; 66(4):476-83. PubMed ID: 17850593
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 17. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ.
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [Abstract] [Full Text] [Related]

  • 18. Treatment of rheumatoid arthritis with rituximab: an update and possible indications.
    De Vita S, Quartuccio L.
    Autoimmun Rev; 2006 Aug; 5(7):443-8. PubMed ID: 16920570
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
    Higashida J, Wun T, Schmidt S, Naguwa SM, Tuscano JM.
    J Rheumatol; 2005 Nov; 32(11):2109-15. PubMed ID: 16265687
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.